| Description | Pexelizumab (h5G1.1-SC), a humanized scFv monoclonal antibody, targets the C5 complement component, thereby inhibiting apoptosis and leukocyte infiltration. It is utilized in researching cerebral ischemia-reperfusion (IR) injury and myocardial infarction [1] [2]. |
| molecular weight | N/A |
| CAS | 219685-93-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |